Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS
- PMID: 33172960
- PMCID: PMC7713721
- DOI: 10.1212/NXI.0000000000000906
Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS
Abstract
Objective: To investigate cross-sectional associations of CSF levels of neurofilament light chain (NfL) and of the newly emerging marker chitinase 3-like protein 1 (CHI3L1) with brain and spinal cord atrophy, which are established MRI markers of disease activity in MS, to study CHI3L1 and NfL in relapsing (RMS) and progressive MS (PMS), and to assess the expression of CHI3L1 in different cell types.
Methods: In a single-center study, 131 patients with MS (42 RMS and 89 PMS) were assessed for NfL and CHI3L1 concentrations in CSF, MRI-based spinal cord and brain volumetry, MS subtype, age, disease duration, and disability. We included 42 matched healthy controls receiving MRI. CHI3L1 expression of human brain cell types was examined in 2 published single-cell RNA sequencing data sets.
Results: CHI3L1 was associated with spinal cord volume (B = -1.07, 95% CI -2.04 to -0.11, p = 0.029) but not with brain volumes. NfL was associated with brain gray matter (B = -7.3, 95% CI -12.0 to -2.7, p = 0.003) but not with spinal cord volume. CHI3L1 was suitable to differentiate between progressive or relapsing MS (p = 0.015, OR 1.0103, CI for OR 1.002-1.0187), and its gene expression was found in MS-associated microglia and macrophages and in astrocytes of MS brains.
Conclusions: NfL and CHI3L1 in CSF were differentially related to brain and spinal cord atrophy. CSF CHI3L1 was associated with spinal cord volume loss and was less affected than NfL by disease duration and age, whereas CSF NfL was associated with brain gray matter atrophy. CSF NfL and CHI3L1 measurement provides complementary information regarding brain and spinal cord volumes.
Classification of evidence: This study provides Class II evidence that CSF CHI3L1 is associated with spinal cord volume loss and that CSF NfL is associated with gray matter atrophy.
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Figures
Similar articles
-
Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.Mult Scler. 2019 Oct;25(11):1444-1451. doi: 10.1177/1352458518794308. Epub 2018 Aug 16. Mult Scler. 2019. PMID: 30113249
-
Potential Role of CHI3L1+ Astrocytes in Progression in MS.Neurol Neuroimmunol Neuroinflamm. 2021 Mar 3;8(3):e972. doi: 10.1212/NXI.0000000000000972. Print 2021 May 4. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33658322 Free PMC article.
-
CSF chitinase 3-like-1 association with disability of primary progressive MS.Neurol Neuroimmunol Neuroinflamm. 2020 Jul 1;7(5):e815. doi: 10.1212/NXI.0000000000000815. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32611760 Free PMC article.
-
Neurofilaments in progressive multiple sclerosis: a systematic review.J Neurol. 2021 Sep;268(9):3212-3222. doi: 10.1007/s00415-020-09917-x. Epub 2020 May 23. J Neurol. 2021. PMID: 32447549 Free PMC article. Review.
-
Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study.Neuropsychiatr Dis Treat. 2018 Sep 3;14:2241-2254. doi: 10.2147/NDT.S173280. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 30214214 Free PMC article. Review.
Cited by
-
Protein biomarkers in multiple sclerosis.Encephalitis. 2023 Apr;3(2):54-63. doi: 10.47936/encephalitis.2022.00101. Epub 2023 Apr 4. Encephalitis. 2023. PMID: 37469674 Free PMC article. Review.
-
The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?Int J Mol Sci. 2023 Jul 5;24(13):11112. doi: 10.3390/ijms241311112. Int J Mol Sci. 2023. PMID: 37446290 Free PMC article. Review.
-
Biomarkers in autoimmune diseases of the central nervous system.Front Immunol. 2023 Apr 5;14:1111719. doi: 10.3389/fimmu.2023.1111719. eCollection 2023. Front Immunol. 2023. PMID: 37090723 Free PMC article. Review.
-
Chitinase Signature in the Plasticity of Neurodegenerative Diseases.Int J Mol Sci. 2023 Mar 27;24(7):6301. doi: 10.3390/ijms24076301. Int J Mol Sci. 2023. PMID: 37047273 Free PMC article. Review.
-
Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis.Neurol Sci. 2023 Sep;44(9):3243-3252. doi: 10.1007/s10072-023-06764-2. Epub 2023 Mar 29. Neurol Sci. 2023. PMID: 36988727 Free PMC article.
References
-
- Haghikia A, Hohlfeld R, Gold R, Fugger L. Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends Mol Med 2013;19:309–319. - PubMed
-
- Teunissen CE, Khalil M. Neurofilaments as biomarkers in multiple sclerosis. Mult Scler 2012;18:552–556. - PubMed
-
- Håkansson I, Tisell A, Cassel P, et al. . Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis. Eur J Neurol 2017;24:703–712. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials